Pharma & Healthcare
Global Biopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 291501
- Pages: 173
- Figures: 166
- Views: 32
In 2024, the global market size of Biopharmaceuticals was estimated to be worth US$ 37750 million and is forecast to reach approximately US$ 64210 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
China Biopharmaceuticals market size was US$ million in 2024, while the US and Europe Biopharmaceuticals were US$ million and US$ million, severally. The proportion of the US was % in 2024, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2031, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Biopharmaceuticals landscape, Germany is projected to reach US$ million by 2031 trailing a CAGR of % over the forecast period.
The global key companies of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
In 2024, Monoclonal Antibodies segment accounted for a share of % in the global Biopharmaceuticals market. And this product segment is poised to reach US$ million by 2031 from US$ million in 2024.
In Biopharmaceuticals market, the Tumor segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2031, at a CAGR of % during 2025 and 2031.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals.
The Biopharmaceuticals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira （Pfizer）
MYLAN
Sun pharma
Segment by Type
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Biopharmaceuticals in global and regional level.
Chapter 3: Detailed analysis of Biopharmaceuticals company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceuticals revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
China Biopharmaceuticals market size was US$ million in 2024, while the US and Europe Biopharmaceuticals were US$ million and US$ million, severally. The proportion of the US was % in 2024, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2031, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Biopharmaceuticals landscape, Germany is projected to reach US$ million by 2031 trailing a CAGR of % over the forecast period.
The global key companies of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
In 2024, Monoclonal Antibodies segment accounted for a share of % in the global Biopharmaceuticals market. And this product segment is poised to reach US$ million by 2031 from US$ million in 2024.
In Biopharmaceuticals market, the Tumor segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2031, at a CAGR of % during 2025 and 2031.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals.
The Biopharmaceuticals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira （Pfizer）
MYLAN
Sun pharma
Segment by Type
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Biopharmaceuticals in global and regional level.
Chapter 3: Detailed analysis of Biopharmaceuticals company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceuticals revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Biopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Colony-Stimulating Factor
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biopharmaceuticals Market Size Estimates and Forecasts
2.2 Biopharmaceuticals Market Size by Region: 2024 Versus 2031
2.2.1 Global Biopharmaceuticals Revenue by Region: 2020-2025
2.2.2 Global Biopharmaceuticals Revenue Forecast by Region (2026-2031)
2.2.3 Global Biopharmaceuticals Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biopharmaceuticals Revenue by Type (2020-2031)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biopharmaceuticals Revenue by Application (2020-2031)
3.2.2 Global Biopharmaceuticals Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Monoclonal Antibodies of Biopharmaceuticals Revenue Market Share by Application
3.3.2 Interferon of Biopharmaceuticals Revenue Market Share by Application
3.3.3 Colony-Stimulating Factor of Biopharmaceuticals Revenue Market Share by Application
3.3.4 Erythropoietin of Biopharmaceuticals Revenue Market Share by Application
3.3.5 Insulin of Biopharmaceuticals Revenue Market Share by Application
3.3.6 Vaccines of Biopharmaceuticals Revenue Market Share by Application
3.3.7 Growth Hormones of Biopharmaceuticals Revenue Market Share by Application
3.3.8 Others of Biopharmaceuticals Revenue Market Share by Application
4 Global Biopharmaceuticals by Company
4.1 Global Biopharmaceuticals Revenue by Company (2020-2025)
4.2 Global Biopharmaceuticals Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Biopharmaceuticals Companies around the World: Ranking by Revenue
4.3.2 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Biopharmaceuticals Companies Headquarters & Product Type
4.4.1 Global Biopharmaceuticals Companies Headquarters
4.4.2 Date of International Companies Enter into Biopharmaceuticals Market
4.4.3 Global Biopharmaceuticals Companies Product & Service
4.4.4 Monoclonal Antibodies Revenue Market Share of Biopharmaceuticals by Company
4.4.5 Interferon Revenue Market Share of Biopharmaceuticals by Company
4.4.6 Colony-Stimulating Factor Revenue Market Share of Biopharmaceuticals by Company
4.4.7 Erythropoietin Revenue Market Share of Biopharmaceuticals by Company
4.4.8 Insulin Revenue Market Share of Biopharmaceuticals by Company
4.4.9 Vaccines Revenue Market Share of Biopharmaceuticals by Company
4.4.10 Growth Hormones Revenue Market Share of Biopharmaceuticals by Company
4.4.11 Others Revenue Market Share of Biopharmaceuticals by Company
4.5 Global Biopharmaceuticals Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Biopharmaceuticals Products Offered
5.1.4 Roche Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.1.5 Roche Biopharmaceuticals Revenue by Product in 2024
5.1.6 Roche Biopharmaceuticals Revenue by Application in 2024
5.1.7 Roche Biopharmaceuticals Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Amgen
5.2.1 Amgen Corporation Information
5.2.2 Amgen Description, Business Overview
5.2.3 Amgen Biopharmaceuticals Products Offered
5.2.4 Amgen Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.2.5 Amgen Biopharmaceuticals Revenue by Product in 2024
5.2.6 Amgen Biopharmaceuticals Revenue by Application in 2024
5.2.7 Amgen Biopharmaceuticals Revenue by Geographic Area in 2024
5.2.8 Amgen Recent Developments
5.3 AbbVie
5.3.1 AbbVie Corporation Information
5.3.2 AbbVie Description, Business Overview
5.3.3 AbbVie Biopharmaceuticals Products Offered
5.3.4 AbbVie Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.3.5 AbbVie Biopharmaceuticals Revenue by Product in 2024
5.3.6 AbbVie Biopharmaceuticals Revenue by Application in 2024
5.3.7 AbbVie Biopharmaceuticals Revenue by Geographic Area in 2024
5.3.8 AbbVie Recent Developments
5.4 Sanofi-Aventis
5.4.1 Sanofi-Aventis Corporation Information
5.4.2 Sanofi-Aventis Description, Business Overview
5.4.3 Sanofi-Aventis Biopharmaceuticals Products Offered
5.4.4 Sanofi-Aventis Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.4.5 Sanofi-Aventis Biopharmaceuticals Revenue by Product in 2024
5.4.6 Sanofi-Aventis Biopharmaceuticals Revenue by Application in 2024
5.4.7 Sanofi-Aventis Biopharmaceuticals Revenue by Geographic Area in 2024
5.4.8 Sanofi-Aventis Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Corporation Information
5.5.2 Johnson & Johnson Description, Business Overview
5.5.3 Johnson & Johnson Biopharmaceuticals Products Offered
5.5.4 Johnson & Johnson Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.5.5 Johnson & Johnson Biopharmaceuticals Revenue by Product in 2024
5.5.6 Johnson & Johnson Biopharmaceuticals Revenue by Application in 2024
5.5.7 Johnson & Johnson Biopharmaceuticals Revenue by Geographic Area in 2024
5.5.8 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Corporation Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Biopharmaceuticals Products Offered
5.6.4 Pfizer Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Biopharmaceuticals Revenue by Product in 2024
5.6.6 Pfizer Biopharmaceuticals Revenue by Application in 2024
5.6.7 Pfizer Biopharmaceuticals Revenue by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Novo Nordisk
5.7.1 Novo Nordisk Corporation Information
5.7.2 Novo Nordisk Description, Business Overview
5.7.3 Novo Nordisk Biopharmaceuticals Products Offered
5.7.4 Novo Nordisk Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.7.5 Novo Nordisk Biopharmaceuticals Revenue by Product in 2024
5.7.6 Novo Nordisk Biopharmaceuticals Revenue by Application in 2024
5.7.7 Novo Nordisk Biopharmaceuticals Revenue by Geographic Area in 2024
5.7.8 Novo Nordisk Recent Developments
5.8 Eli Lilly
5.8.1 Eli Lilly Corporation Information
5.8.2 Eli Lilly Description, Business Overview
5.8.3 Eli Lilly Biopharmaceuticals Products Offered
5.8.4 Eli Lilly Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.8.5 Eli Lilly Biopharmaceuticals Revenue by Product in 2024
5.8.6 Eli Lilly Biopharmaceuticals Revenue by Application in 2024
5.8.7 Eli Lilly Biopharmaceuticals Revenue by Geographic Area in 2024
5.8.8 Eli Lilly Recent Developments
5.9 Novartis
5.9.1 Novartis Corporation Information
5.9.2 Novartis Description, Business Overview
5.9.3 Novartis Biopharmaceuticals Products Offered
5.9.4 Novartis Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.9.5 Novartis Biopharmaceuticals Revenue by Product in 2024
5.9.6 Novartis Biopharmaceuticals Revenue by Application in 2024
5.9.7 Novartis Biopharmaceuticals Revenue by Geographic Area in 2024
5.9.8 Novartis Recent Developments
5.10 Merck
5.10.1 Merck Corporation Information
5.10.2 Merck Description, Business Overview
5.10.3 Merck Biopharmaceuticals Products Offered
5.10.4 Merck Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.10.5 Merck Biopharmaceuticals Revenue by Product in 2024
5.10.6 Merck Biopharmaceuticals Revenue by Application in 2024
5.10.7 Merck Biopharmaceuticals Revenue by Geographic Area in 2024
5.10.8 Merck Recent Developments
5.11 Sun
5.11.1 Sun Corporation Information
5.11.2 Sun Description, Business Overview
5.11.3 Sun Biopharmaceuticals Products Offered
5.11.4 Sun Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.11.5 Sun Biopharmaceuticals Revenue by Product in 2024
5.11.6 Sun Biopharmaceuticals Revenue by Application in 2024
5.11.7 Sun Biopharmaceuticals Revenue by Geographic Area in 2024
5.11.8 Sun Recent Developments
5.12 3sbio
5.12.1 3sbio Corporation Information
5.12.2 3sbio Description, Business Overview
5.12.3 3sbio Biopharmaceuticals Products Offered
5.12.4 3sbio Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.12.5 3sbio Biopharmaceuticals Revenue by Product in 2024
5.12.6 3sbio Biopharmaceuticals Revenue by Application in 2024
5.12.7 3sbio Biopharmaceuticals Revenue by Geographic Area in 2024
5.12.8 3sbio Recent Developments
5.13 Changchun High Tech
5.13.1 Changchun High Tech Corporation Information
5.13.2 Changchun High Tech Description, Business Overview
5.13.3 Changchun High Tech Biopharmaceuticals Products Offered
5.13.4 Changchun High Tech Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.13.5 Changchun High Tech Biopharmaceuticals Revenue by Product in 2024
5.13.6 Changchun High Tech Biopharmaceuticals Revenue by Application in 2024
5.13.7 Changchun High Tech Biopharmaceuticals Revenue by Geographic Area in 2024
5.13.8 Changchun High Tech Recent Developments
5.14 CP Guojian
5.14.1 CP Guojian Corporation Information
5.14.2 CP Guojian Description, Business Overview
5.14.3 CP Guojian Biopharmaceuticals Products Offered
5.14.4 CP Guojian Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.14.5 CP Guojian Biopharmaceuticals Revenue by Product in 2024
5.14.6 CP Guojian Biopharmaceuticals Revenue by Application in 2024
5.14.7 CP Guojian Biopharmaceuticals Revenue by Geographic Area in 2024
5.14.8 CP Guojian Recent Developments
5.15 Biotech
5.15.1 Biotech Corporation Information
5.15.2 Biotech Description, Business Overview
5.15.3 Biotech Biopharmaceuticals Products Offered
5.15.4 Biotech Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.15.5 Biotech Biopharmaceuticals Revenue by Product in 2024
5.15.6 Biotech Biopharmaceuticals Revenue by Application in 2024
5.15.7 Biotech Biopharmaceuticals Revenue by Geographic Area in 2024
5.15.8 Biotech Recent Developments
5.16 Gelgen
5.16.1 Gelgen Corporation Information
5.16.2 Gelgen Description, Business Overview
5.16.3 Gelgen Biopharmaceuticals Products Offered
5.16.4 Gelgen Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.16.5 Gelgen Biopharmaceuticals Revenue by Product in 2024
5.16.6 Gelgen Biopharmaceuticals Revenue by Application in 2024
5.16.7 Gelgen Biopharmaceuticals Revenue by Geographic Area in 2024
5.16.8 Gelgen Recent Developments
5.17 Innovent
5.17.1 Innovent Corporation Information
5.17.2 Innovent Description, Business Overview
5.17.3 Innovent Biopharmaceuticals Products Offered
5.17.4 Innovent Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.17.5 Innovent Biopharmaceuticals Revenue by Product in 2024
5.17.6 Innovent Biopharmaceuticals Revenue by Application in 2024
5.17.7 Innovent Biopharmaceuticals Revenue by Geographic Area in 2024
5.17.8 Innovent Recent Developments
5.18 Dong Bao
5.18.1 Dong Bao Corporation Information
5.18.2 Dong Bao Description, Business Overview
5.18.3 Dong Bao Biopharmaceuticals Products Offered
5.18.4 Dong Bao Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.18.5 Dong Bao Biopharmaceuticals Revenue by Product in 2024
5.18.6 Dong Bao Biopharmaceuticals Revenue by Application in 2024
5.18.7 Dong Bao Biopharmaceuticals Revenue by Geographic Area in 2024
5.18.8 Dong Bao Recent Developments
5.19 Ganlee
5.19.1 Ganlee Corporation Information
5.19.2 Ganlee Description, Business Overview
5.19.3 Ganlee Biopharmaceuticals Products Offered
5.19.4 Ganlee Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.19.5 Ganlee Biopharmaceuticals Revenue by Product in 2024
5.19.6 Ganlee Biopharmaceuticals Revenue by Application in 2024
5.19.7 Ganlee Biopharmaceuticals Revenue by Geographic Area in 2024
5.19.8 Ganlee Recent Developments
5.20 United Laboratories
5.20.1 United Laboratories Corporation Information
5.20.2 United Laboratories Description, Business Overview
5.20.3 United Laboratories Biopharmaceuticals Products Offered
5.20.4 United Laboratories Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.20.5 United Laboratories Biopharmaceuticals Revenue by Product in 2024
5.20.6 United Laboratories Biopharmaceuticals Revenue by Application in 2024
5.20.7 United Laboratories Biopharmaceuticals Revenue by Geographic Area in 2024
5.20.8 United Laboratories Recent Developments
5.21 SANDOZ (NOVARTIS)
5.21.1 SANDOZ (NOVARTIS) Corporation Information
5.21.2 SANDOZ (NOVARTIS) Description, Business Overview
5.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Products Offered
5.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.21.5 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue by Product in 2024
5.21.6 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue by Application in 2024
5.21.7 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue by Geographic Area in 2024
5.21.8 SANDOZ (NOVARTIS) Recent Developments
5.22 Teva Pharmaceutical
5.22.1 Teva Pharmaceutical Corporation Information
5.22.2 Teva Pharmaceutical Description, Business Overview
5.22.3 Teva Pharmaceutical Biopharmaceuticals Products Offered
5.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.22.5 Teva Pharmaceutical Biopharmaceuticals Revenue by Product in 2024
5.22.6 Teva Pharmaceutical Biopharmaceuticals Revenue by Application in 2024
5.22.7 Teva Pharmaceutical Biopharmaceuticals Revenue by Geographic Area in 2024
5.22.8 Teva Pharmaceutical Recent Developments
5.23 Hospira （Pfizer）
5.23.1 Hospira （Pfizer） Corporation Information
5.23.2 Hospira （Pfizer） Description, Business Overview
5.23.3 Hospira （Pfizer） Biopharmaceuticals Products Offered
5.23.4 Hospira （Pfizer） Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.23.5 Hospira （Pfizer） Biopharmaceuticals Revenue by Product in 2024
5.23.6 Hospira （Pfizer） Biopharmaceuticals Revenue by Application in 2024
5.23.7 Hospira （Pfizer） Biopharmaceuticals Revenue by Geographic Area in 2024
5.23.8 Hospira （Pfizer） Recent Developments
5.24 MYLAN
5.24.1 MYLAN Corporation Information
5.24.2 MYLAN Description, Business Overview
5.24.3 MYLAN Biopharmaceuticals Products Offered
5.24.4 MYLAN Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.24.5 MYLAN Biopharmaceuticals Revenue by Product in 2024
5.24.6 MYLAN Biopharmaceuticals Revenue by Application in 2024
5.24.7 MYLAN Biopharmaceuticals Revenue by Geographic Area in 2024
5.24.8 MYLAN Recent Developments
5.25 Sun pharma
5.25.1 Sun pharma Corporation Information
5.25.2 Sun pharma Description, Business Overview
5.25.3 Sun pharma Biopharmaceuticals Products Offered
5.25.4 Sun pharma Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.25.5 Sun pharma Biopharmaceuticals Revenue by Product in 2024
5.25.6 Sun pharma Biopharmaceuticals Revenue by Application in 2024
5.25.7 Sun pharma Biopharmaceuticals Revenue by Geographic Area in 2024
5.25.8 Sun pharma Recent Developments
6 North America
6.1 North America Biopharmaceuticals Market Size YoY Growth 2020-2031
6.2 North America Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
6.3 North America Biopharmaceuticals Revenue by Type (2020-2025)
6.4 North America Biopharmaceuticals Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biopharmaceuticals Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biopharmaceuticals Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Biopharmaceuticals Revenue by Type (2020-2025)
7.4 Asia-Pacific Biopharmaceuticals Revenue by Application (2020-2025)
8 Europe
8.1 Europe Biopharmaceuticals Market Size YoY Growth 2020-2031
8.2 Europe Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
8.3 Europe Biopharmaceuticals Revenue by Type (2020-2025)
8.4 Europe Biopharmaceuticals Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Biopharmaceuticals Market Size YoY Growth 2020-2031
9.2 Latin America Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
9.3 Latin America Biopharmaceuticals Revenue by Type (2020-2025)
9.4 Latin America Biopharmaceuticals Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biopharmaceuticals Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Biopharmaceuticals Revenue by Type (2020-2025)
10.4 Middle East and Africa Biopharmaceuticals Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biopharmaceuticals Supply Chain Analysis
11.2 Biopharmaceuticals Key Raw Materials and Upstream Suppliers
11.3 Biopharmaceuticals Clients Analysis
11.4 Biopharmaceuticals Sales Channel and Sales Model Analysis
11.4.1 Biopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biopharmaceuticals Distributors
12 Biopharmaceuticals Market Dynamics
12.1 Biopharmaceuticals Industry Trends
12.2 Biopharmaceuticals Market Drivers
12.3 Biopharmaceuticals Market Challenges
12.4 Biopharmaceuticals Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Biopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Colony-Stimulating Factor
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biopharmaceuticals Market Size Estimates and Forecasts
2.2 Biopharmaceuticals Market Size by Region: 2024 Versus 2031
2.2.1 Global Biopharmaceuticals Revenue by Region: 2020-2025
2.2.2 Global Biopharmaceuticals Revenue Forecast by Region (2026-2031)
2.2.3 Global Biopharmaceuticals Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biopharmaceuticals Revenue by Type (2020-2031)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biopharmaceuticals Revenue by Application (2020-2031)
3.2.2 Global Biopharmaceuticals Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Monoclonal Antibodies of Biopharmaceuticals Revenue Market Share by Application
3.3.2 Interferon of Biopharmaceuticals Revenue Market Share by Application
3.3.3 Colony-Stimulating Factor of Biopharmaceuticals Revenue Market Share by Application
3.3.4 Erythropoietin of Biopharmaceuticals Revenue Market Share by Application
3.3.5 Insulin of Biopharmaceuticals Revenue Market Share by Application
3.3.6 Vaccines of Biopharmaceuticals Revenue Market Share by Application
3.3.7 Growth Hormones of Biopharmaceuticals Revenue Market Share by Application
3.3.8 Others of Biopharmaceuticals Revenue Market Share by Application
4 Global Biopharmaceuticals by Company
4.1 Global Biopharmaceuticals Revenue by Company (2020-2025)
4.2 Global Biopharmaceuticals Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Biopharmaceuticals Companies around the World: Ranking by Revenue
4.3.2 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Biopharmaceuticals Companies Headquarters & Product Type
4.4.1 Global Biopharmaceuticals Companies Headquarters
4.4.2 Date of International Companies Enter into Biopharmaceuticals Market
4.4.3 Global Biopharmaceuticals Companies Product & Service
4.4.4 Monoclonal Antibodies Revenue Market Share of Biopharmaceuticals by Company
4.4.5 Interferon Revenue Market Share of Biopharmaceuticals by Company
4.4.6 Colony-Stimulating Factor Revenue Market Share of Biopharmaceuticals by Company
4.4.7 Erythropoietin Revenue Market Share of Biopharmaceuticals by Company
4.4.8 Insulin Revenue Market Share of Biopharmaceuticals by Company
4.4.9 Vaccines Revenue Market Share of Biopharmaceuticals by Company
4.4.10 Growth Hormones Revenue Market Share of Biopharmaceuticals by Company
4.4.11 Others Revenue Market Share of Biopharmaceuticals by Company
4.5 Global Biopharmaceuticals Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Biopharmaceuticals Products Offered
5.1.4 Roche Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.1.5 Roche Biopharmaceuticals Revenue by Product in 2024
5.1.6 Roche Biopharmaceuticals Revenue by Application in 2024
5.1.7 Roche Biopharmaceuticals Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Amgen
5.2.1 Amgen Corporation Information
5.2.2 Amgen Description, Business Overview
5.2.3 Amgen Biopharmaceuticals Products Offered
5.2.4 Amgen Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.2.5 Amgen Biopharmaceuticals Revenue by Product in 2024
5.2.6 Amgen Biopharmaceuticals Revenue by Application in 2024
5.2.7 Amgen Biopharmaceuticals Revenue by Geographic Area in 2024
5.2.8 Amgen Recent Developments
5.3 AbbVie
5.3.1 AbbVie Corporation Information
5.3.2 AbbVie Description, Business Overview
5.3.3 AbbVie Biopharmaceuticals Products Offered
5.3.4 AbbVie Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.3.5 AbbVie Biopharmaceuticals Revenue by Product in 2024
5.3.6 AbbVie Biopharmaceuticals Revenue by Application in 2024
5.3.7 AbbVie Biopharmaceuticals Revenue by Geographic Area in 2024
5.3.8 AbbVie Recent Developments
5.4 Sanofi-Aventis
5.4.1 Sanofi-Aventis Corporation Information
5.4.2 Sanofi-Aventis Description, Business Overview
5.4.3 Sanofi-Aventis Biopharmaceuticals Products Offered
5.4.4 Sanofi-Aventis Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.4.5 Sanofi-Aventis Biopharmaceuticals Revenue by Product in 2024
5.4.6 Sanofi-Aventis Biopharmaceuticals Revenue by Application in 2024
5.4.7 Sanofi-Aventis Biopharmaceuticals Revenue by Geographic Area in 2024
5.4.8 Sanofi-Aventis Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Corporation Information
5.5.2 Johnson & Johnson Description, Business Overview
5.5.3 Johnson & Johnson Biopharmaceuticals Products Offered
5.5.4 Johnson & Johnson Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.5.5 Johnson & Johnson Biopharmaceuticals Revenue by Product in 2024
5.5.6 Johnson & Johnson Biopharmaceuticals Revenue by Application in 2024
5.5.7 Johnson & Johnson Biopharmaceuticals Revenue by Geographic Area in 2024
5.5.8 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Corporation Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Biopharmaceuticals Products Offered
5.6.4 Pfizer Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Biopharmaceuticals Revenue by Product in 2024
5.6.6 Pfizer Biopharmaceuticals Revenue by Application in 2024
5.6.7 Pfizer Biopharmaceuticals Revenue by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Novo Nordisk
5.7.1 Novo Nordisk Corporation Information
5.7.2 Novo Nordisk Description, Business Overview
5.7.3 Novo Nordisk Biopharmaceuticals Products Offered
5.7.4 Novo Nordisk Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.7.5 Novo Nordisk Biopharmaceuticals Revenue by Product in 2024
5.7.6 Novo Nordisk Biopharmaceuticals Revenue by Application in 2024
5.7.7 Novo Nordisk Biopharmaceuticals Revenue by Geographic Area in 2024
5.7.8 Novo Nordisk Recent Developments
5.8 Eli Lilly
5.8.1 Eli Lilly Corporation Information
5.8.2 Eli Lilly Description, Business Overview
5.8.3 Eli Lilly Biopharmaceuticals Products Offered
5.8.4 Eli Lilly Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.8.5 Eli Lilly Biopharmaceuticals Revenue by Product in 2024
5.8.6 Eli Lilly Biopharmaceuticals Revenue by Application in 2024
5.8.7 Eli Lilly Biopharmaceuticals Revenue by Geographic Area in 2024
5.8.8 Eli Lilly Recent Developments
5.9 Novartis
5.9.1 Novartis Corporation Information
5.9.2 Novartis Description, Business Overview
5.9.3 Novartis Biopharmaceuticals Products Offered
5.9.4 Novartis Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.9.5 Novartis Biopharmaceuticals Revenue by Product in 2024
5.9.6 Novartis Biopharmaceuticals Revenue by Application in 2024
5.9.7 Novartis Biopharmaceuticals Revenue by Geographic Area in 2024
5.9.8 Novartis Recent Developments
5.10 Merck
5.10.1 Merck Corporation Information
5.10.2 Merck Description, Business Overview
5.10.3 Merck Biopharmaceuticals Products Offered
5.10.4 Merck Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.10.5 Merck Biopharmaceuticals Revenue by Product in 2024
5.10.6 Merck Biopharmaceuticals Revenue by Application in 2024
5.10.7 Merck Biopharmaceuticals Revenue by Geographic Area in 2024
5.10.8 Merck Recent Developments
5.11 Sun
5.11.1 Sun Corporation Information
5.11.2 Sun Description, Business Overview
5.11.3 Sun Biopharmaceuticals Products Offered
5.11.4 Sun Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.11.5 Sun Biopharmaceuticals Revenue by Product in 2024
5.11.6 Sun Biopharmaceuticals Revenue by Application in 2024
5.11.7 Sun Biopharmaceuticals Revenue by Geographic Area in 2024
5.11.8 Sun Recent Developments
5.12 3sbio
5.12.1 3sbio Corporation Information
5.12.2 3sbio Description, Business Overview
5.12.3 3sbio Biopharmaceuticals Products Offered
5.12.4 3sbio Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.12.5 3sbio Biopharmaceuticals Revenue by Product in 2024
5.12.6 3sbio Biopharmaceuticals Revenue by Application in 2024
5.12.7 3sbio Biopharmaceuticals Revenue by Geographic Area in 2024
5.12.8 3sbio Recent Developments
5.13 Changchun High Tech
5.13.1 Changchun High Tech Corporation Information
5.13.2 Changchun High Tech Description, Business Overview
5.13.3 Changchun High Tech Biopharmaceuticals Products Offered
5.13.4 Changchun High Tech Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.13.5 Changchun High Tech Biopharmaceuticals Revenue by Product in 2024
5.13.6 Changchun High Tech Biopharmaceuticals Revenue by Application in 2024
5.13.7 Changchun High Tech Biopharmaceuticals Revenue by Geographic Area in 2024
5.13.8 Changchun High Tech Recent Developments
5.14 CP Guojian
5.14.1 CP Guojian Corporation Information
5.14.2 CP Guojian Description, Business Overview
5.14.3 CP Guojian Biopharmaceuticals Products Offered
5.14.4 CP Guojian Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.14.5 CP Guojian Biopharmaceuticals Revenue by Product in 2024
5.14.6 CP Guojian Biopharmaceuticals Revenue by Application in 2024
5.14.7 CP Guojian Biopharmaceuticals Revenue by Geographic Area in 2024
5.14.8 CP Guojian Recent Developments
5.15 Biotech
5.15.1 Biotech Corporation Information
5.15.2 Biotech Description, Business Overview
5.15.3 Biotech Biopharmaceuticals Products Offered
5.15.4 Biotech Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.15.5 Biotech Biopharmaceuticals Revenue by Product in 2024
5.15.6 Biotech Biopharmaceuticals Revenue by Application in 2024
5.15.7 Biotech Biopharmaceuticals Revenue by Geographic Area in 2024
5.15.8 Biotech Recent Developments
5.16 Gelgen
5.16.1 Gelgen Corporation Information
5.16.2 Gelgen Description, Business Overview
5.16.3 Gelgen Biopharmaceuticals Products Offered
5.16.4 Gelgen Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.16.5 Gelgen Biopharmaceuticals Revenue by Product in 2024
5.16.6 Gelgen Biopharmaceuticals Revenue by Application in 2024
5.16.7 Gelgen Biopharmaceuticals Revenue by Geographic Area in 2024
5.16.8 Gelgen Recent Developments
5.17 Innovent
5.17.1 Innovent Corporation Information
5.17.2 Innovent Description, Business Overview
5.17.3 Innovent Biopharmaceuticals Products Offered
5.17.4 Innovent Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.17.5 Innovent Biopharmaceuticals Revenue by Product in 2024
5.17.6 Innovent Biopharmaceuticals Revenue by Application in 2024
5.17.7 Innovent Biopharmaceuticals Revenue by Geographic Area in 2024
5.17.8 Innovent Recent Developments
5.18 Dong Bao
5.18.1 Dong Bao Corporation Information
5.18.2 Dong Bao Description, Business Overview
5.18.3 Dong Bao Biopharmaceuticals Products Offered
5.18.4 Dong Bao Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.18.5 Dong Bao Biopharmaceuticals Revenue by Product in 2024
5.18.6 Dong Bao Biopharmaceuticals Revenue by Application in 2024
5.18.7 Dong Bao Biopharmaceuticals Revenue by Geographic Area in 2024
5.18.8 Dong Bao Recent Developments
5.19 Ganlee
5.19.1 Ganlee Corporation Information
5.19.2 Ganlee Description, Business Overview
5.19.3 Ganlee Biopharmaceuticals Products Offered
5.19.4 Ganlee Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.19.5 Ganlee Biopharmaceuticals Revenue by Product in 2024
5.19.6 Ganlee Biopharmaceuticals Revenue by Application in 2024
5.19.7 Ganlee Biopharmaceuticals Revenue by Geographic Area in 2024
5.19.8 Ganlee Recent Developments
5.20 United Laboratories
5.20.1 United Laboratories Corporation Information
5.20.2 United Laboratories Description, Business Overview
5.20.3 United Laboratories Biopharmaceuticals Products Offered
5.20.4 United Laboratories Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.20.5 United Laboratories Biopharmaceuticals Revenue by Product in 2024
5.20.6 United Laboratories Biopharmaceuticals Revenue by Application in 2024
5.20.7 United Laboratories Biopharmaceuticals Revenue by Geographic Area in 2024
5.20.8 United Laboratories Recent Developments
5.21 SANDOZ (NOVARTIS)
5.21.1 SANDOZ (NOVARTIS) Corporation Information
5.21.2 SANDOZ (NOVARTIS) Description, Business Overview
5.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Products Offered
5.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.21.5 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue by Product in 2024
5.21.6 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue by Application in 2024
5.21.7 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue by Geographic Area in 2024
5.21.8 SANDOZ (NOVARTIS) Recent Developments
5.22 Teva Pharmaceutical
5.22.1 Teva Pharmaceutical Corporation Information
5.22.2 Teva Pharmaceutical Description, Business Overview
5.22.3 Teva Pharmaceutical Biopharmaceuticals Products Offered
5.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.22.5 Teva Pharmaceutical Biopharmaceuticals Revenue by Product in 2024
5.22.6 Teva Pharmaceutical Biopharmaceuticals Revenue by Application in 2024
5.22.7 Teva Pharmaceutical Biopharmaceuticals Revenue by Geographic Area in 2024
5.22.8 Teva Pharmaceutical Recent Developments
5.23 Hospira （Pfizer）
5.23.1 Hospira （Pfizer） Corporation Information
5.23.2 Hospira （Pfizer） Description, Business Overview
5.23.3 Hospira （Pfizer） Biopharmaceuticals Products Offered
5.23.4 Hospira （Pfizer） Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.23.5 Hospira （Pfizer） Biopharmaceuticals Revenue by Product in 2024
5.23.6 Hospira （Pfizer） Biopharmaceuticals Revenue by Application in 2024
5.23.7 Hospira （Pfizer） Biopharmaceuticals Revenue by Geographic Area in 2024
5.23.8 Hospira （Pfizer） Recent Developments
5.24 MYLAN
5.24.1 MYLAN Corporation Information
5.24.2 MYLAN Description, Business Overview
5.24.3 MYLAN Biopharmaceuticals Products Offered
5.24.4 MYLAN Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.24.5 MYLAN Biopharmaceuticals Revenue by Product in 2024
5.24.6 MYLAN Biopharmaceuticals Revenue by Application in 2024
5.24.7 MYLAN Biopharmaceuticals Revenue by Geographic Area in 2024
5.24.8 MYLAN Recent Developments
5.25 Sun pharma
5.25.1 Sun pharma Corporation Information
5.25.2 Sun pharma Description, Business Overview
5.25.3 Sun pharma Biopharmaceuticals Products Offered
5.25.4 Sun pharma Biopharmaceuticals Revenue and Gross Margin (2020-2025)
5.25.5 Sun pharma Biopharmaceuticals Revenue by Product in 2024
5.25.6 Sun pharma Biopharmaceuticals Revenue by Application in 2024
5.25.7 Sun pharma Biopharmaceuticals Revenue by Geographic Area in 2024
5.25.8 Sun pharma Recent Developments
6 North America
6.1 North America Biopharmaceuticals Market Size YoY Growth 2020-2031
6.2 North America Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
6.3 North America Biopharmaceuticals Revenue by Type (2020-2025)
6.4 North America Biopharmaceuticals Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biopharmaceuticals Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biopharmaceuticals Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Biopharmaceuticals Revenue by Type (2020-2025)
7.4 Asia-Pacific Biopharmaceuticals Revenue by Application (2020-2025)
8 Europe
8.1 Europe Biopharmaceuticals Market Size YoY Growth 2020-2031
8.2 Europe Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
8.3 Europe Biopharmaceuticals Revenue by Type (2020-2025)
8.4 Europe Biopharmaceuticals Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Biopharmaceuticals Market Size YoY Growth 2020-2031
9.2 Latin America Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
9.3 Latin America Biopharmaceuticals Revenue by Type (2020-2025)
9.4 Latin America Biopharmaceuticals Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biopharmaceuticals Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biopharmaceuticals Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Biopharmaceuticals Revenue by Type (2020-2025)
10.4 Middle East and Africa Biopharmaceuticals Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biopharmaceuticals Supply Chain Analysis
11.2 Biopharmaceuticals Key Raw Materials and Upstream Suppliers
11.3 Biopharmaceuticals Clients Analysis
11.4 Biopharmaceuticals Sales Channel and Sales Model Analysis
11.4.1 Biopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biopharmaceuticals Distributors
12 Biopharmaceuticals Market Dynamics
12.1 Biopharmaceuticals Industry Trends
12.2 Biopharmaceuticals Market Drivers
12.3 Biopharmaceuticals Market Challenges
12.4 Biopharmaceuticals Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceuticals Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biopharmaceuticals Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biopharmaceuticals Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Biopharmaceuticals Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Biopharmaceuticals Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Biopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 11. Biopharmaceuticals Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Biopharmaceuticals Players by Revenue (US$ Million) in 2024
Table 13. Global Biopharmaceuticals Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2024)
Table 15. Global Biopharmaceuticals Companies Headquarters
Table 16. Date of International Companies Enter into Biopharmaceuticals Market
Table 17. Global Biopharmaceuticals Companies Product & Service
Table 18. Global Biopharmaceuticals Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche Biopharmaceuticals Product
Table 22. Roche Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 24. Roche Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 25. Roche Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Amgen Corporation Information
Table 28. Amgen Description and Business Overview
Table 29. Amgen Biopharmaceuticals Product
Table 30. Amgen Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Amgen Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 32. Amgen Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 33. Amgen Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 34. Amgen Recent Developments
Table 35. AbbVie Corporation Information
Table 36. AbbVie Description and Business Overview
Table 37. AbbVie Biopharmaceuticals Product
Table 38. AbbVie Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. AbbVie Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 40. AbbVie Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 41. AbbVie Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 42. AbbVie Recent Developments
Table 43. Sanofi-Aventis Corporation Information
Table 44. Sanofi-Aventis Description and Business Overview
Table 45. Sanofi-Aventis Biopharmaceuticals Product
Table 46. Sanofi-Aventis Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Sanofi-Aventis Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 48. Sanofi-Aventis Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 49. Sanofi-Aventis Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 50. Sanofi-Aventis Recent Developments
Table 51. Johnson & Johnson Corporation Information
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Biopharmaceuticals Product
Table 54. Johnson & Johnson Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Johnson & Johnson Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 56. Johnson & Johnson Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 57. Johnson & Johnson Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 58. Johnson & Johnson Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Biopharmaceuticals Product
Table 62. Pfizer Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Pfizer Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 64. Pfizer Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 65. Pfizer Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 66. Pfizer Recent Developments
Table 67. Novo Nordisk Corporation Information
Table 68. Novo Nordisk Description and Business Overview
Table 69. Novo Nordisk Biopharmaceuticals Product
Table 70. Novo Nordisk Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Novo Nordisk Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 72. Novo Nordisk Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 73. Novo Nordisk Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 74. Novo Nordisk Recent Developments
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Biopharmaceuticals Product
Table 78. Eli Lilly Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Eli Lilly Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 80. Eli Lilly Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 81. Eli Lilly Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 82. Eli Lilly Recent Developments
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Biopharmaceuticals Product
Table 86. Novartis Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Novartis Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 88. Novartis Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 89. Novartis Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 90. Novartis Recent Developments
Table 91. Merck Corporation Information
Table 92. Merck Description and Business Overview
Table 93. Merck Biopharmaceuticals Product
Table 94. Merck Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Merck Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 96. Merck Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 97. Merck Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 98. Merck Recent Developments
Table 99. Sun Corporation Information
Table 100. Sun Description and Business Overview
Table 101. Sun Biopharmaceuticals Product
Table 102. Sun Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Sun Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 104. Sun Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 105. Sun Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 106. Sun Recent Developments
Table 107. 3sbio Corporation Information
Table 108. 3sbio Description and Business Overview
Table 109. 3sbio Biopharmaceuticals Product
Table 110. 3sbio Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. 3sbio Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 112. 3sbio Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 113. 3sbio Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 114. 3sbio Recent Developments
Table 115. Changchun High Tech Corporation Information
Table 116. Changchun High Tech Description and Business Overview
Table 117. Changchun High Tech Biopharmaceuticals Product
Table 118. Changchun High Tech Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Changchun High Tech Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 120. Changchun High Tech Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 121. Changchun High Tech Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 122. Changchun High Tech Recent Developments
Table 123. CP Guojian Corporation Information
Table 124. CP Guojian Description and Business Overview
Table 125. CP Guojian Biopharmaceuticals Product
Table 126. CP Guojian Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. CP Guojian Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 128. CP Guojian Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 129. CP Guojian Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 130. CP Guojian Recent Developments
Table 131. Biotech Corporation Information
Table 132. Biotech Description and Business Overview
Table 133. Biotech Biopharmaceuticals Product
Table 134. Biotech Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Biotech Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 136. Biotech Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 137. Biotech Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 138. Biotech Recent Developments
Table 139. Gelgen Corporation Information
Table 140. Gelgen Description and Business Overview
Table 141. Gelgen Biopharmaceuticals Product
Table 142. Gelgen Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Gelgen Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 144. Gelgen Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 145. Gelgen Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 146. Gelgen Recent Developments
Table 147. Innovent Corporation Information
Table 148. Innovent Description and Business Overview
Table 149. Innovent Biopharmaceuticals Product
Table 150. Innovent Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Innovent Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 152. Innovent Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 153. Innovent Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 154. Innovent Recent Developments
Table 155. Dong Bao Corporation Information
Table 156. Dong Bao Description and Business Overview
Table 157. Dong Bao Biopharmaceuticals Product
Table 158. Dong Bao Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Dong Bao Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 160. Dong Bao Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 161. Dong Bao Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 162. Dong Bao Recent Developments
Table 163. Ganlee Corporation Information
Table 164. Ganlee Description and Business Overview
Table 165. Ganlee Biopharmaceuticals Product
Table 166. Ganlee Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Ganlee Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 168. Ganlee Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 169. Ganlee Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 170. Ganlee Recent Developments
Table 171. United Laboratories Corporation Information
Table 172. United Laboratories Description and Business Overview
Table 173. United Laboratories Biopharmaceuticals Product
Table 174. United Laboratories Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. United Laboratories Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 176. United Laboratories Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 177. United Laboratories Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 178. United Laboratories Recent Developments
Table 179. SANDOZ (NOVARTIS) Corporation Information
Table 180. SANDOZ (NOVARTIS) Description and Business Overview
Table 181. SANDOZ (NOVARTIS) Biopharmaceuticals Product
Table 182. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. SANDOZ (NOVARTIS) Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 184. SANDOZ (NOVARTIS) Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 185. SANDOZ (NOVARTIS) Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 186. SANDOZ (NOVARTIS) Recent Developments
Table 187. Teva Pharmaceutical Corporation Information
Table 188. Teva Pharmaceutical Description and Business Overview
Table 189. Teva Pharmaceutical Biopharmaceuticals Product
Table 190. Teva Pharmaceutical Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 191. Teva Pharmaceutical Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 192. Teva Pharmaceutical Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 193. Teva Pharmaceutical Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 194. Teva Pharmaceutical Recent Developments
Table 195. Hospira （Pfizer） Corporation Information
Table 196. Hospira （Pfizer） Description and Business Overview
Table 197. Hospira （Pfizer） Biopharmaceuticals Product
Table 198. Hospira （Pfizer） Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 199. Hospira （Pfizer） Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 200. Hospira （Pfizer） Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 201. Hospira （Pfizer） Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 202. Hospira （Pfizer） Recent Developments
Table 203. MYLAN Corporation Information
Table 204. MYLAN Description and Business Overview
Table 205. MYLAN Biopharmaceuticals Product
Table 206. MYLAN Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 207. MYLAN Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 208. MYLAN Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 209. MYLAN Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 210. MYLAN Recent Developments
Table 211. Sun pharma Corporation Information
Table 212. Sun pharma Description and Business Overview
Table 213. Sun pharma Biopharmaceuticals Product
Table 214. Sun pharma Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 215. Sun pharma Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 216. Sun pharma Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 217. Sun pharma Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 218. Sun pharma Recent Developments
Table 219. North America Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 220. North America Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 221. North America Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 222. North America Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 223. Asia-Pacific Biopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 224. Asia-Pacific Biopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
Table 225. Asia-Pacific Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 226. Asia-Pacific Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 227. Europe Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 228. Europe Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 229. Europe Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 230. Europe Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 231. Latin America Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 232. Latin America Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 233. Latin America Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 234. Latin America Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 235. Middle East and Africa Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 236. Middle East and Africa Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 237. Middle East and Africa Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 238. Middle East and Africa Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 239. Biopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 240. Biopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 241. Biopharmaceuticals Clients Status and Trend
Table 242. Biopharmaceuticals Typical Clients
Table 243. Biopharmaceuticals Distributors
Table 244. Biopharmaceuticals Market Trends
Table 245. Biopharmaceuticals Market Drivers
Table 246. Biopharmaceuticals Market Challenges
Table 247. Biopharmaceuticals Market Restraints
Table 248. Research Programs/Design for This Report
Table 249. Key Data Information from Secondary Sources
Table 250. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceuticals Product Picture
Figure 2. Global Biopharmaceuticals Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biopharmaceuticals Revenue Market Share by Type in 2024 & 2031
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Interferon Product Picture
Figure 6. Colony-Stimulating Factor Product Picture
Figure 7. Erythropoietin Product Picture
Figure 8. Insulin Product Picture
Figure 9. Vaccines Product Picture
Figure 10. Growth Hormones Product Picture
Figure 11. Others Product Picture
Figure 12. Global Biopharmaceuticals Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 13. Global Biopharmaceuticals Revenue Market Share by Application in 2024 & 2031
Figure 14. Tumor
Figure 15. Diabetes
Figure 16. Cardiovascular
Figure 17. Hemophilia
Figure 18. Others
Figure 19. Biopharmaceuticals Report Years Considered
Figure 20. Global Biopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Biopharmaceuticals Market Size (2020-2031) & (US$ Million)
Figure 22. Global Biopharmaceuticals Market Size Market Share by Region: 2024 Versus 2031
Figure 23. Global Biopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 24. Global Biopharmaceuticals Revenue Market Share Forecast by Type (2020-2031)
Figure 25. Global Biopharmaceuticals Revenue Market Share Forecast by Application (2020-2031)
Figure 26. Monoclonal Antibodies of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 27. Interferon of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 28. Colony-Stimulating Factor of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 29. Erythropoietin of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 30. Insulin of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 31. Vaccines of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 32. Growth Hormones of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 33. Others of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 34. Biopharmaceuticals Revenue Share by Company (2024)
Figure 35. Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Monoclonal Antibodies Revenue Proportion by Company in 2024
Figure 37. Interferon Revenue Proportion by Company in 2024
Figure 38. Colony-Stimulating Factor Revenue Proportion by Company in 2024
Figure 39. Erythropoietin Revenue Proportion by Company in 2024
Figure 40. Insulin Revenue Proportion by Company in 2024
Figure 41. Vaccines Revenue Proportion by Company in 2024
Figure 42. Growth Hormones Revenue Proportion by Company in 2024
Figure 43. Others Revenue Proportion by Company in 2024
Figure 44. North America Biopharmaceuticals Revenue 2020-2031 (US$ Million)
Figure 45. North America Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 46. North America Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 47. Asia-Pacific Biopharmaceuticals Revenue 2020-2031 (US$ Million)
Figure 48. Asia-Pacific Biopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 49. Asia-Pacific Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 50. Asia-Pacific Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 51. Europe Biopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 52. Europe Biopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 53. Europe Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 54. Europe Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 55. Latin America Biopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Latin America Biopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 57. Latin America Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 58. Latin America Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 59. Middle East and Africa Biopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 60. Middle East and Africa Biopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 62. Middle East and Africa Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 63. Biopharmaceuticals Supply Chain (Upstream and Downstream Market)
Figure 64. Global Production Market Share of Biopharmaceuticals Raw Materials by Region in 2024
Figure 65. Biopharmaceuticals Distribution Channels
Figure 66. Global Biopharmaceuticals Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 67. Global Biopharmaceuticals Percentage 2020-2031: Online Sales VS Offline Sales
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Biopharmaceuticals Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biopharmaceuticals Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biopharmaceuticals Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Biopharmaceuticals Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Biopharmaceuticals Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Biopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 11. Biopharmaceuticals Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Biopharmaceuticals Players by Revenue (US$ Million) in 2024
Table 13. Global Biopharmaceuticals Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2024)
Table 15. Global Biopharmaceuticals Companies Headquarters
Table 16. Date of International Companies Enter into Biopharmaceuticals Market
Table 17. Global Biopharmaceuticals Companies Product & Service
Table 18. Global Biopharmaceuticals Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche Biopharmaceuticals Product
Table 22. Roche Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 24. Roche Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 25. Roche Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Amgen Corporation Information
Table 28. Amgen Description and Business Overview
Table 29. Amgen Biopharmaceuticals Product
Table 30. Amgen Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Amgen Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 32. Amgen Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 33. Amgen Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 34. Amgen Recent Developments
Table 35. AbbVie Corporation Information
Table 36. AbbVie Description and Business Overview
Table 37. AbbVie Biopharmaceuticals Product
Table 38. AbbVie Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. AbbVie Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 40. AbbVie Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 41. AbbVie Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 42. AbbVie Recent Developments
Table 43. Sanofi-Aventis Corporation Information
Table 44. Sanofi-Aventis Description and Business Overview
Table 45. Sanofi-Aventis Biopharmaceuticals Product
Table 46. Sanofi-Aventis Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Sanofi-Aventis Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 48. Sanofi-Aventis Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 49. Sanofi-Aventis Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 50. Sanofi-Aventis Recent Developments
Table 51. Johnson & Johnson Corporation Information
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Biopharmaceuticals Product
Table 54. Johnson & Johnson Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Johnson & Johnson Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 56. Johnson & Johnson Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 57. Johnson & Johnson Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 58. Johnson & Johnson Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Biopharmaceuticals Product
Table 62. Pfizer Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Pfizer Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 64. Pfizer Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 65. Pfizer Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 66. Pfizer Recent Developments
Table 67. Novo Nordisk Corporation Information
Table 68. Novo Nordisk Description and Business Overview
Table 69. Novo Nordisk Biopharmaceuticals Product
Table 70. Novo Nordisk Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Novo Nordisk Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 72. Novo Nordisk Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 73. Novo Nordisk Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 74. Novo Nordisk Recent Developments
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Biopharmaceuticals Product
Table 78. Eli Lilly Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Eli Lilly Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 80. Eli Lilly Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 81. Eli Lilly Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 82. Eli Lilly Recent Developments
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Biopharmaceuticals Product
Table 86. Novartis Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Novartis Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 88. Novartis Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 89. Novartis Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 90. Novartis Recent Developments
Table 91. Merck Corporation Information
Table 92. Merck Description and Business Overview
Table 93. Merck Biopharmaceuticals Product
Table 94. Merck Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Merck Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 96. Merck Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 97. Merck Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 98. Merck Recent Developments
Table 99. Sun Corporation Information
Table 100. Sun Description and Business Overview
Table 101. Sun Biopharmaceuticals Product
Table 102. Sun Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Sun Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 104. Sun Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 105. Sun Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 106. Sun Recent Developments
Table 107. 3sbio Corporation Information
Table 108. 3sbio Description and Business Overview
Table 109. 3sbio Biopharmaceuticals Product
Table 110. 3sbio Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. 3sbio Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 112. 3sbio Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 113. 3sbio Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 114. 3sbio Recent Developments
Table 115. Changchun High Tech Corporation Information
Table 116. Changchun High Tech Description and Business Overview
Table 117. Changchun High Tech Biopharmaceuticals Product
Table 118. Changchun High Tech Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Changchun High Tech Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 120. Changchun High Tech Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 121. Changchun High Tech Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 122. Changchun High Tech Recent Developments
Table 123. CP Guojian Corporation Information
Table 124. CP Guojian Description and Business Overview
Table 125. CP Guojian Biopharmaceuticals Product
Table 126. CP Guojian Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. CP Guojian Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 128. CP Guojian Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 129. CP Guojian Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 130. CP Guojian Recent Developments
Table 131. Biotech Corporation Information
Table 132. Biotech Description and Business Overview
Table 133. Biotech Biopharmaceuticals Product
Table 134. Biotech Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Biotech Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 136. Biotech Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 137. Biotech Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 138. Biotech Recent Developments
Table 139. Gelgen Corporation Information
Table 140. Gelgen Description and Business Overview
Table 141. Gelgen Biopharmaceuticals Product
Table 142. Gelgen Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Gelgen Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 144. Gelgen Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 145. Gelgen Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 146. Gelgen Recent Developments
Table 147. Innovent Corporation Information
Table 148. Innovent Description and Business Overview
Table 149. Innovent Biopharmaceuticals Product
Table 150. Innovent Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Innovent Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 152. Innovent Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 153. Innovent Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 154. Innovent Recent Developments
Table 155. Dong Bao Corporation Information
Table 156. Dong Bao Description and Business Overview
Table 157. Dong Bao Biopharmaceuticals Product
Table 158. Dong Bao Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Dong Bao Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 160. Dong Bao Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 161. Dong Bao Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 162. Dong Bao Recent Developments
Table 163. Ganlee Corporation Information
Table 164. Ganlee Description and Business Overview
Table 165. Ganlee Biopharmaceuticals Product
Table 166. Ganlee Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Ganlee Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 168. Ganlee Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 169. Ganlee Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 170. Ganlee Recent Developments
Table 171. United Laboratories Corporation Information
Table 172. United Laboratories Description and Business Overview
Table 173. United Laboratories Biopharmaceuticals Product
Table 174. United Laboratories Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. United Laboratories Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 176. United Laboratories Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 177. United Laboratories Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 178. United Laboratories Recent Developments
Table 179. SANDOZ (NOVARTIS) Corporation Information
Table 180. SANDOZ (NOVARTIS) Description and Business Overview
Table 181. SANDOZ (NOVARTIS) Biopharmaceuticals Product
Table 182. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. SANDOZ (NOVARTIS) Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 184. SANDOZ (NOVARTIS) Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 185. SANDOZ (NOVARTIS) Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 186. SANDOZ (NOVARTIS) Recent Developments
Table 187. Teva Pharmaceutical Corporation Information
Table 188. Teva Pharmaceutical Description and Business Overview
Table 189. Teva Pharmaceutical Biopharmaceuticals Product
Table 190. Teva Pharmaceutical Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 191. Teva Pharmaceutical Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 192. Teva Pharmaceutical Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 193. Teva Pharmaceutical Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 194. Teva Pharmaceutical Recent Developments
Table 195. Hospira （Pfizer） Corporation Information
Table 196. Hospira （Pfizer） Description and Business Overview
Table 197. Hospira （Pfizer） Biopharmaceuticals Product
Table 198. Hospira （Pfizer） Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 199. Hospira （Pfizer） Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 200. Hospira （Pfizer） Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 201. Hospira （Pfizer） Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 202. Hospira （Pfizer） Recent Developments
Table 203. MYLAN Corporation Information
Table 204. MYLAN Description and Business Overview
Table 205. MYLAN Biopharmaceuticals Product
Table 206. MYLAN Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 207. MYLAN Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 208. MYLAN Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 209. MYLAN Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 210. MYLAN Recent Developments
Table 211. Sun pharma Corporation Information
Table 212. Sun pharma Description and Business Overview
Table 213. Sun pharma Biopharmaceuticals Product
Table 214. Sun pharma Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 215. Sun pharma Revenue Proportion of Biopharmaceuticals by Product in 2024
Table 216. Sun pharma Revenue Proportion of Biopharmaceuticals by Application in 2024
Table 217. Sun pharma Revenue Proportion of Biopharmaceuticals by Geographic Area in 2024
Table 218. Sun pharma Recent Developments
Table 219. North America Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 220. North America Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 221. North America Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 222. North America Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 223. Asia-Pacific Biopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 224. Asia-Pacific Biopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
Table 225. Asia-Pacific Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 226. Asia-Pacific Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 227. Europe Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 228. Europe Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 229. Europe Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 230. Europe Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 231. Latin America Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 232. Latin America Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 233. Latin America Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 234. Latin America Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 235. Middle East and Africa Biopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 236. Middle East and Africa Biopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 237. Middle East and Africa Biopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 238. Middle East and Africa Biopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 239. Biopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 240. Biopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 241. Biopharmaceuticals Clients Status and Trend
Table 242. Biopharmaceuticals Typical Clients
Table 243. Biopharmaceuticals Distributors
Table 244. Biopharmaceuticals Market Trends
Table 245. Biopharmaceuticals Market Drivers
Table 246. Biopharmaceuticals Market Challenges
Table 247. Biopharmaceuticals Market Restraints
Table 248. Research Programs/Design for This Report
Table 249. Key Data Information from Secondary Sources
Table 250. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceuticals Product Picture
Figure 2. Global Biopharmaceuticals Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biopharmaceuticals Revenue Market Share by Type in 2024 & 2031
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Interferon Product Picture
Figure 6. Colony-Stimulating Factor Product Picture
Figure 7. Erythropoietin Product Picture
Figure 8. Insulin Product Picture
Figure 9. Vaccines Product Picture
Figure 10. Growth Hormones Product Picture
Figure 11. Others Product Picture
Figure 12. Global Biopharmaceuticals Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 13. Global Biopharmaceuticals Revenue Market Share by Application in 2024 & 2031
Figure 14. Tumor
Figure 15. Diabetes
Figure 16. Cardiovascular
Figure 17. Hemophilia
Figure 18. Others
Figure 19. Biopharmaceuticals Report Years Considered
Figure 20. Global Biopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Biopharmaceuticals Market Size (2020-2031) & (US$ Million)
Figure 22. Global Biopharmaceuticals Market Size Market Share by Region: 2024 Versus 2031
Figure 23. Global Biopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 24. Global Biopharmaceuticals Revenue Market Share Forecast by Type (2020-2031)
Figure 25. Global Biopharmaceuticals Revenue Market Share Forecast by Application (2020-2031)
Figure 26. Monoclonal Antibodies of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 27. Interferon of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 28. Colony-Stimulating Factor of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 29. Erythropoietin of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 30. Insulin of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 31. Vaccines of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 32. Growth Hormones of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 33. Others of Biopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 34. Biopharmaceuticals Revenue Share by Company (2024)
Figure 35. Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Monoclonal Antibodies Revenue Proportion by Company in 2024
Figure 37. Interferon Revenue Proportion by Company in 2024
Figure 38. Colony-Stimulating Factor Revenue Proportion by Company in 2024
Figure 39. Erythropoietin Revenue Proportion by Company in 2024
Figure 40. Insulin Revenue Proportion by Company in 2024
Figure 41. Vaccines Revenue Proportion by Company in 2024
Figure 42. Growth Hormones Revenue Proportion by Company in 2024
Figure 43. Others Revenue Proportion by Company in 2024
Figure 44. North America Biopharmaceuticals Revenue 2020-2031 (US$ Million)
Figure 45. North America Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 46. North America Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 47. Asia-Pacific Biopharmaceuticals Revenue 2020-2031 (US$ Million)
Figure 48. Asia-Pacific Biopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 49. Asia-Pacific Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 50. Asia-Pacific Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 51. Europe Biopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 52. Europe Biopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 53. Europe Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 54. Europe Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 55. Latin America Biopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Latin America Biopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 57. Latin America Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 58. Latin America Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 59. Middle East and Africa Biopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 60. Middle East and Africa Biopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Biopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 62. Middle East and Africa Biopharmaceuticals Revenue Market Share by Application (2020-2025)
Figure 63. Biopharmaceuticals Supply Chain (Upstream and Downstream Market)
Figure 64. Global Production Market Share of Biopharmaceuticals Raw Materials by Region in 2024
Figure 65. Biopharmaceuticals Distribution Channels
Figure 66. Global Biopharmaceuticals Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 67. Global Biopharmaceuticals Percentage 2020-2031: Online Sales VS Offline Sales
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232